Last updated: about 1 month ago
AstraZeneca's Breakthrough: Baxdrostat Shines in Phase III Hypertension Trial
AstraZeneca's Baxdrostat shows significant promise in treating uncontrolled hypertension, marking a major advancement in cardiovascular medicine.